Lipocine Inc. (LPCN) Social Stream



Lipocine Inc. (LPCN): $0.32

-0.01 (-2.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LIPOCINE INC (LPCN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LPCN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 3 $6 $2.5 $3.75 $0.317 1082.97%
2022-05-10 2 $6 $2.5 $3.75 $0.317 1082.97%
2022-05-20 2 $5.5 $2.5 $3.625 $0.317 1043.53%
2022-08-10 2 $5.5 $2 $3.375 $0.317 964.67%
2022-11-10 2 $5.5 $2 $3.333 $0.317 951.42%
2023-03-13 2 $5.5 $2 $3.833 $0.317 1109.15%
2023-03-16 2 $5 $2 $3.666 $0.317 1056.47%

The Trend in the Analyst Price Target


LPCN's average price target has moved down $0.83 over the prior 20 months.

Over the past 44 weeks, LPCN's average upside potential has been 576.05%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-10 2 6.0 2.5 3.750 0.760 393.42%
2022-08-09 2 5.5 2.0 3.375 0.725 365.52%
2022-08-10 2 5.5 2.0 3.333 0.712 368.12%
2022-11-10 2 5.5 2.0 3.333 0.379 779.42%
2022-11-10 2 5.5 2.0 3.833 0.379 911.35%

LPCN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


Over the past 17 months, LPCN's average broker recommendation rating improved by 0.67.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • LPCN has a greater average analyst price target than 14.97% of all US stocks.
  • In terms of how LIPOCINE INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 674.03% of that group.
  • In terms of how LIPOCINE INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 28.24% of that group.
  • LPCN has a lower variance in analysts' estimates than -469.86% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LIPOCINE INC are VSTM, RGLS, and KPTI.

What is the outlook for LPCN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7313 seconds.